Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06441955 · ClinicalTrials.gov registry record · Phase 4
Covid-19 Long Haul Preventative and Health Promotion Care Clinical Trial Acceleration Program.
A Phase 4 study of COVID-19, Long Haul, sponsored by Well- Konnect Healthcare Services and Research Firm.
- Recruiting
- Registry status
- Phase 4
- Development phase
- 100
- Enrollment target
- 1
- Study location
NCT06441955 is a Phase 4 study of COVID-19, Long Haul that is actively recruiting participants, run by Well- Konnect Healthcare Services and Research Firm. The registered enrollment target is 100 participants. The trial reports 1 study location across 1 state.
The verdict
NCT06441955, a Phase 4 study of COVID-19, Long Haul, is actively recruiting participants, sponsored by Well- Konnect Healthcare Services and Research Firm.
- RECRUITING
- Registry status
- Phase 4
- Development phase
- 100 participants
- Enrollment target
- 1
- Study location
Study Summary
Investigators are conducting a study on alternative treatments for patients who have received an current or previous positive COVID-19 diagnosis with mild-serve symptoms or undiagnosable condition after testing positive for severe acute COVID-19 infection and are experiencing long-haul symptoms. The symptoms of long COVID can include extreme tiredness (fatigue), shortness of breath, memory and concentration issues (brain fog), heart palpitations, dizziness, joint pain, muscle aches, cough, headaches, anxiety, and depression. It's important to note that there are various other symptoms that individuals can experience after a COVID-19 infection, such as loss of smell, chest pain or tightness, difficulty sleeping (insomnia), pins and needles, depression, anxiety, tinnitus, earaches, nausea, diarrhea, stomach aches, loss of appetite, cough, headaches, sore throat, and changes to the sense of smell or taste. To be included in the study, participants must have had symptoms for more than 4 weeks. The goal of the study is to measure biomarkers, identify new ones through clinical trials, and individualize and optimize treatment plans, which may or may not include COVID-19 post-market antivirals, vaccines, and medical care. It's essential to conduct thorough clinical trials to understand the long-term effects of COVID-19 and to develop personalized treatment plans for individuals experiencing long-haul symptoms.
Conditions Studied
Interventions
- DRUG Ritonavir-Boosted Nirmatrelvir (Paxlovid)
- DIAGNOSTIC_TEST Physiological Evaluation
- BIOLOGICAL Moderna COVID-19 Vaccine
- BEHAVIORAL Biopsychological
- BEHAVIORAL Behavioral (e.g., Psychotherapy, Lifestyle Counseling)
Study Locations (1)
Maryland
- NIH Clinical Center - Bethesda
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 100 participants |
| Start Date | 2024-03-01 |
| Est. Completion | 2030-09-30 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06441955
The ClinicalTrials.gov registry entry for NCT06441955 describes a study currently listed as recruiting, categorized as Phase 4. The registered enrollment target is 100 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Well- Konnect Healthcare Services and Research Firm, which has 1 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with COVID-19, Long Haul appearing as the primary indexed condition, and to 5 interventions - of which Ritonavir-Boosted Nirmatrelvir (Paxlovid) is the first listed.
NCT06441955 reports 1 study location spanning 1 distinct geographic area - top geographies include Maryland.
Frequently Asked Questions
What is clinical trial NCT06441955 about?
NCT06441955 is a clinical study titled "Covid-19 Long Haul Preventative and Health Promotion Care Clinical Trial Acceleration Program.". Investigators are conducting a study on alternative treatments for patients who have received an current or previous positive COVID-19 diagnosis with mild-serve symptoms or undiagnosable condition after testing positive for severe acute COVID-19 infection and are experiencing long-haul symptoms. The...
What is the current status of trial NCT06441955?
This trial is currently recruiting. It is a Phase 4 study. The enrollment target is 100 participants. The study started on 2024-03-01. Estimated completion is 2030-09-30.
What conditions does trial NCT06441955 study?
This clinical trial studies the following conditions: COVID-19, Long Haul.
What interventions are being tested in trial NCT06441955?
The interventions under investigation include: Ritonavir-Boosted Nirmatrelvir (Paxlovid) (DRUG), Physiological Evaluation (DIAGNOSTIC_TEST), Moderna COVID-19 Vaccine (BIOLOGICAL), Biopsychological (BEHAVIORAL), Behavioral (e.g., Psychotherapy, Lifestyle Counseling) (BEHAVIORAL).
Who is sponsoring clinical trial NCT06441955?
This trial is sponsored by Well- Konnect Healthcare Services and Research Firm, which has 1 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06441955 being conducted?
This trial has 1 study location across Maryland. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.